NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $436,594 | +298.9% | 60,303 | +309.4% | 0.00% | – |
Q2 2023 | $109,436 | +23.6% | 14,729 | +15.2% | 0.00% | – |
Q1 2023 | $88,572 | -32.4% | 12,781 | +0.3% | 0.00% | -100.0% |
Q4 2022 | $130,947 | -49.6% | 12,738 | -11.0% | 0.00% | -50.0% |
Q3 2022 | $260,000 | -79.6% | 14,308 | -42.4% | 0.00% | -71.4% |
Q2 2022 | $1,277,000 | -68.6% | 24,829 | -55.0% | 0.01% | -65.0% |
Q1 2022 | $4,067,000 | +13.2% | 55,219 | +119.9% | 0.02% | +17.6% |
Q4 2021 | $3,592,000 | -19.5% | 25,110 | +16.6% | 0.02% | -29.2% |
Q3 2021 | $4,464,000 | +6.3% | 21,535 | +8.9% | 0.02% | +4.3% |
Q2 2021 | $4,199,000 | +201.9% | 19,778 | +157.9% | 0.02% | +187.5% |
Q1 2021 | $1,391,000 | +40.1% | 7,670 | -13.8% | 0.01% | +33.3% |
Q4 2020 | $993,000 | +40.3% | 8,902 | +36.2% | 0.01% | +20.0% |
Q3 2020 | $708,000 | +51.9% | 6,534 | +16.8% | 0.01% | +25.0% |
Q2 2020 | $466,000 | +6557.1% | 5,594 | +301.3% | 0.00% | – |
Q3 2019 | $7,000 | -12.5% | 1,394 | 0.0% | 0.00% | – |
Q2 2019 | $8,000 | – | 1,394 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 4,758,833 | $396,649,000 | 7.73% |
TSP Capital Management Group, LLC | 72,575 | $6,049,000 | 2.58% |
Beirne Wealth Consulting Services, LLC | 22,250 | $1,855,000 | 1.51% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 93,000 | $7,752,000 | 1.41% |
Rock Springs Capital Management LP | 570,598 | $47,559,000 | 1.30% |
Sargent Investment Group, LLC | 38,059 | $3,033,000 | 1.14% |
Harvest Investment Services, LLC | 19,580 | $1,631,000 | 0.97% |
Parkman Healthcare Partners LLC | 40,000 | $3,334,000 | 0.94% |
EAM Investors, LLC | 39,055 | $3,255,000 | 0.72% |
EAM Global Investors LLC | 17,774 | $1,481,000 | 0.67% |